Sunscreen has become one of beauty’s fastest-moving innovation categories.
Brands compete through invisible fluids, cooling gels, skincare ingredients, serum textures and products that sit perfectly beneath makeup.
But beneath that innovation lies a more fundamental question:
Does the protection inside the bottle match the number printed on it?
Between 2025 and 2026, three major Asian-Pacific sunscreen markets placed renewed attention on that question.
- • Australia responded to dramatic independent test failures with recalls, investigations and proposed regulatory reform.
- • India published a dedicated national SPF-testing standard aligned with an international in-vivo method.
- • South Korea continued refining a functional-cosmetics system strengthened after earlier Korean sunscreens failed independent SPF tests.
These were not one coordinated international crackdown.
They were separate responses to the same structural weakness:
Sunscreen brands have become exceptionally good at innovating around texture and marketing, while consumers remain largely unable to verify the product’s central performance claim.
This is one signal from the Consensys Innovation Signals Engine, which continuously scans a library of more than one million products worldwide for emerging shifts in formulation, positioning and consumer demand.
Australia exposed the trust problem in public
Australia’s sunscreen crisis began with an independent investigation by consumer organisation CHOICE.
In 2025, CHOICE purchased 20 sunscreens labelled SPF 50 or SPF 50+ and submitted them for specialist laboratory testing.
Only four met their labelled claims.
The most extreme result came from Ultra Violette Lean Screen SPF 50+ Mattifying Zinc Skinscreen, which returned an SPF of four. A repeat test on another batch at a separate accredited laboratory returned an SPF of five.
The product was subsequently recalled and removed from the Australian Register of Therapeutic Goods. The Therapeutic Goods Administration then identified numerous products linked to the same underlying base formulation. By March 31, 2026, the regulator reported that 19 products targeted through that investigation had been cancelled and recalled.
The Australian case made the problem unusually visible.
This was not an abstract debate about laboratory standards. Consumers could compare a bottle labelled SPF 50+ with a reported result of SPF four.
Australia’s system relied heavily on evidence held by companies
Australian primary sunscreens are generally regulated as therapeutic goods, but many enter the market as listed products rather than undergoing a complete individual premarket evaluation.
Sponsors must hold evidence supporting the product’s safety, quality and performance. Historically, however, the complete SPF evidence was not necessarily examined by the TGA before every listed sunscreen reached consumers.
The CHOICE investigation therefore exposed a weakness in the evidence architecture:
- • Brands held test reports.
- • Contract manufacturers could supply related formulas to multiple brands.
- • Laboratories sometimes returned materially different results.
- • The regulator often became deeply involved only after a problem emerged.
Australia’s consultation proposed stronger testing requirements, laboratory oversight, transparency and closer alignment between evidence and the exact finished product.
India created a more specific testing benchmark
India’s sunscreen market has expanded rapidly through domestic beauty startups, dermatology-led brands and e-commerce.
The category also developed an evidence problem.
Brands frequently promoted:
- • SPF 30, 50 or 50+
- • PA+++ or PA++++
- • Broad-spectrum protection
- • Blue-light protection
- • Water resistance
- • Clinical or dermatological testing
Yet test methods and the amount of evidence disclosed to consumers varied significantly.
In September 2025, the Bureau of Indian Standards published IS 17494:2025, titled Sun Protection Factor—SPF—In Vivo Test Method. The standard modifies and adopts the internationally recognised ISO 24444:2019 method for measuring SPF on human participants.
This is an important technical development.
It gives Indian laboratories, manufacturers and regulators a nationally specified method for determining SPF rather than leaving brands to refer loosely to unspecified internal or overseas testing.
“New standard” does not automatically mean “mandatory for every product”
The original the original row states that IS 17494:2025 became mandatory across India in January 2026.
That should not be published without a supporting government order.
A BIS standard can be:
- • Voluntary
- • Referenced within another regulation
- • Required through a Quality Control Order
- • Incorporated into licensing or enforcement requirements
- • Used as the recognised benchmark when substantiating claims
The publication of IS 17494:2025 is confirmed. I did not find an official BIS, CDSCO or Gazette notification establishing that every sunscreen sold in India became legally required to comply with it from January 1, 2026.
India’s wider cosmetics framework is governed through the Cosmetics Rules, 2020, administered by central and state authorities.
The safest classification is therefore:
The standard still changes the competitive environment
Even without overstating its legal status, IS 17494:2025 creates pressure on Indian sunscreen brands.
Products making high-SPF claims can increasingly be expected to disclose:
- • The testing method
- • The testing laboratory
- • Whether the finished commercial formula was tested
- • The number and type of subjects used
- • Whether UVA protection was assessed separately
- • Whether water-resistance claims were tested
- • Whether the report applies to the current formulation
Brands including Dr. Sheth’s and Dot & Key have already begun using compliance with recognised in-vivo testing as a consumer-facing trust signal. Their explanations demonstrate how laboratory methodology is becoming part of sunscreen marketing rather than remaining hidden inside regulatory files.
South Korea’s reckoning began earlier
South Korea does not fit neatly into the “same 12-month crackdown” thesis.
Its major sunscreen-trust crisis occurred in 2020 and 2021, when several internationally popular Korean sunscreens—including products associated with Purito and Klairs—returned independent SPF results significantly below their labelled claims.
The controversy damaged confidence in Korean sunscreen testing and led brands to withdraw or reformulate affected products.
South Korea’s Ministry of Food and Drug Safety subsequently revised its functional-cosmetics evaluation framework. In 2021, it added recognised ISO testing methods and clarified the evidence required for SPF and water-resistance claims.
Under Korea’s system, sunscreens are treated as functional cosmetics. A responsible seller must undergo MFDS evaluation or submit the required safety and effectiveness report before marketing the relevant functional claim.
South Korea did amend cosmetic safety requirements in 2025 and 2026, including changes involving UV filters and test methods. These updates show continued regulatory development, but they are not evidence of a fresh SPF-accuracy crackdown equivalent to Australia’s CHOICE-triggered investigation.
The three markets are addressing different points of failure
The similarities are real, but so are the differences.
Australia: Post-market evidence failure
Products already on shelves produced independent results that conflicted dramatically with labelled SPF claims.
India: Method standardisation
A rapidly expanding category needed a clearer nationally specified test method.
South Korea: Functional-claim verification
An earlier scandal exposed failures involving products developed and tested through external networks.
These are three stages of the same product-evidence chain:
Test the formula correctly → connect the result to the finished product → verify that commercial batches continue to perform as claimed
There is no evidence of one coordinated crackdown
No public evidence found for this article shows that BIS, TGA and MFDS jointly coordinated these changes.
The more plausible explanation is independent convergence.
The regulators operate within different legal systems:
- • Australian sunscreens are often therapeutic goods.
- • Indian sunscreens are regulated through the cosmetics framework and applicable standards.
- • Korean sunscreens are functional cosmetics.
They also responded to different triggers and timelines.
What connects them is not a shared enforcement operation. It is exposure to the same global industry conditions:
- • Complex international supply chains
- • Contract formulation and manufacturing
- • Reliance on specialist testing laboratories
- • Rapid brand launches
- • Cross-border e-commerce
- • High consumer dependence on label claims
- • Scientific variability in human SPF testing
The laboratory problem is global
Traditional SPF testing relies on human skin.
A fixed amount of sunscreen is applied, the skin is exposed to controlled ultraviolet radiation and researchers assess the dose required to produce visible redness.
The method has several weaknesses:
- • Human responses vary.
- • Application must be highly consistent.
- • Visual assessment can be subjective.
- • Different laboratories may produce different results.
- • Testing is expensive and time-consuming.
- • Ethical concerns arise from deliberately exposing skin to UV radiation.
These limitations do not mean the method is useless. ISO 24444 remains the established international reference for in-vivo SPF determination.
They do explain why the industry is searching for more reproducible alternatives.
Europe is changing test methods too
The global reform story extends beyond the three markets in the original row.
In December 2024, the International Organization for Standardization published ISO 23675:2024, an in-vitro method for determining static SPF in suitable sunscreen formulations.
The method uses laboratory plates rather than human skin and is intended as an alternative to the traditional in-vivo standard for applicable product types.
Cosmetics Europe publicly supported the scientific development in January 2025 and revised its industry recommendation in June 2025 to incorporate validated alternative SPF methods.
The standard was adopted in Europe as EN ISO 23675:2025.
This is not a crackdown caused by mass product failures.
It is a parallel attempt to improve the reproducibility, ethics and scalability of SPF testing.
A better method will not solve every failure
Testing reform is necessary, but several problems can occur after the laboratory result is produced.
A brand may:
- • Test a base formula rather than the exact finished product
- • Change a fragrance, pigment or preservative
- • Move manufacturing to another facility
- • Use evidence from an earlier formulation
- • Misinterpret a laboratory report
- • Apply an SPF result across related products
- • Experience batch instability during storage
A highly accurate test is valuable only when it is connected to the product consumers actually buy.
That makes finished-product traceability as important as the test method itself.
Testing laboratories are becoming part of the brand story
Historically, consumers rarely knew which laboratory tested a sunscreen.
That may change.
The Australian scandal demonstrated that laboratories could become central to a brand’s credibility—or its crisis.
Future proof-led brands may disclose:
- • Laboratory name
- • Accreditation
- • Test date
- • Product batch
- • Exact standard used
- • SPF result
- • UVA protection result
- • Water-resistance result
- • Repeat-test result
- • Current-formula confirmation
This would turn a laboratory report from a confidential compliance document into a consumer-facing product asset.
Shared formulations create shared risk
Modern sunscreen brands often use contract manufacturers and third-party formula developers.
This allows smaller companies to launch advanced products without owning a laboratory or factory.
It also allows one base formula to appear across several brands.
Australia showed what happens when uncertainty around one formulation spreads through an entire product cluster.
The regulatory response is likely to increase pressure for:
- • Manufacturer disclosure
- • Base-formula identification
- • Finished-product testing
- • Change-control documentation
- • Cross-brand traceability
- • Periodic retesting
The consumer cannot verify SPF at home
A shopper can judge whether a sunscreen:
- • Feels greasy
- • Leaves a white cast
- • Pills under makeup
- • Irritates the eyes
- • Smells pleasant
They cannot judge whether it is truly SPF 30, 50 or 50+.
A person may use an underperforming sunscreen for months without realising it. Sun damage can accumulate without an immediate visible signal.
That asymmetry makes sunscreen different from most beauty products.
The central benefit is invisible, and failure may not become obvious until much later.
The next competitive frontier is proof
Sunscreen innovation has spent years improving the application experience.
The next phase will focus more heavily on proving protection.
Leading brands may compete through:
- • Public test summaries
- • Multiple-laboratory verification
- • Finished-product testing
- • Batch-level traceability
- • QR-linked evidence
- • Clear UVA metrics
- • Periodic retesting
- • Transparent formula changes
- • Independent post-market sampling
The product claim will no longer end with SPF 50+.
Consumers will increasingly ask:
Tested where, by whom, using which method, on which version of the product?
This is a global reckoning—but not one simultaneous crackdown
Australia, India and South Korea should not be forced into one inaccurate timeline.
Australia experienced a dramatic 2025–2026 product and regulatory crisis.
India published an important new national testing standard in 2025, although its exact mandatory status requires firmer government documentation.
South Korea’s major reform cycle began several years earlier and continues through its functional-cosmetics framework.
Europe, meanwhile, has been advancing new in-vitro testing standards.
Together, these developments reveal something larger than one national scandal:
The sunscreen industry is moving from claim-led trust toward evidence-led trust.
The global convergence is real.
The crackdowns are not identical.
Brand Radar Signal Tags
Regulators and Organisations
Bureau of Indian Standards BIS Therapeutic Goods Administration TGA CHOICE Ministry of Food and Drug Safety MFDS Cosmetics Europe International Organization for Standardization ISO Central Drugs Standard Control Organization CDSCO
Brands and Products
Ultra Violette Ultra Violette Lean Screen SPF 50+ Purito Klairs Dr. Sheth’s Dot & Key
Standards and Methods
IS 17494:2025 ISO 24444:2019 ISO 23675:2024 EN ISO 23675:2025 In-Vivo SPF Testing In-Vitro SPF Testing Double-Plate Method Functional Cosmetics Evaluation
Innovation Types
SPF Test Standardisation Regulatory Evidence Reform Test-Method Transparency Finished-Product Verification Formula-to-Claim Traceability Evidence-Led Premiumisation Post-Market Surveillance Laboratory Accountability Batch-Level Verification
Risk Signals
SPF Claim Failure Label-to-Performance Gap Laboratory Variability Shared-Formulation Risk Sponsor-Held Evidence Unverified Mandatory-Date Claim Formula-Platform Contagion Consumer Trust Erosion Regulatory Fragmentation
Market Signals
Global SPF Verification Shift Independent Regulatory Convergence Sunscreen Trust Reckoning Proof-Led Sun Care Cross-Border Formula Scrutiny Testing Method Modernisation Asia-Pacific Regulatory Reform
Geography
India Australia South Korea European Union Global Sun-Care Market
Sources
India
- • Bureau of Indian Standards — official standards platform: https://standards.bis.gov.in/
- • IS 17494:2025 publication record: The national SPF in-vivo testing standard was published on September 24, 2025 and modifies ISO 24444:2019. https://elle.in/beauty/india-finally-has-a-sunscreen-rulebook-heres-what-that-means-for-your-skin-10798352
- • CDSCO — Cosmetics Rules, 2020: India’s national cosmetics regulatory framework.
- • Industry explanations of IS 17494:2025: Indian brands have begun presenting recognised in-vivo testing as a consumer trust signal.
Australia
- • CHOICE and TGA investigation: Independent testing found 16 of 20 products below their labelled SPF claims, including Ultra Violette Lean Screen at SPF four.
- • TGA reform proposals: Reporting on the 2026 reform process described stronger laboratory oversight, evidence requirements and transparency.
South Korea
- • MFDS — Functional cosmetics framework: Sunscreen products making functional claims require evaluation or reporting of safety and effectiveness evidence.
- • 2021 functional-cosmetics evaluation revision: South Korea incorporated recognised ISO SPF methods and clarified submission requirements after the earlier Korean sunscreen controversy.
- • 2025–2026 cosmetic-safety updates: MFDS continued revising UV-filter and testing requirements, but these updates were not a new scandal-driven crackdown equivalent to Australia’s.
Europe and international testing
- • Cosmetics Europe — Development of ISO 23675: The organisation described the publication of the new in-vitro double-plate SPF method in January 2025.
- • Cosmetics Europe Recommendation No. 26: The June 2025 recommendation supports validated alternatives to traditional in-vivo SPF testing.
- • EN ISO 23675:2025: European adoption of the in-vitro SPF standard.